IP Library Granted Patent US 9,777,270
Granted Patent B2
US 9,777,270 · App. 14/965,816 · Granted Oct 3, 2017

Methods and compositions for selecting siRNA of improved functionality

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,777,270
App. No.
14/965,816
Granted
Oct 3, 2017
Kind
B2
Abstract

Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to nucleotide sequences for TTR.

Claims (15)

1. An siRNA molecule, wherein said siRNA molecule consists of:

(a) a duplex region; and (b) either no overhang regions or at least one overhang region, wherein each overhang region contains six or fewer nucleotides, wherein the duplex region consists of a sense region and an antisense region, wherein said sense region and said antisense region together form said duplex region and said sense region and said antisense region are each 19-30 nucleotides in length and said antisense region comprises a sequence that is the complement of SEQ ID NO:461.

2. The siRNA molecule of claim 1 , wherein said antisense region and said sense region are each 19-25 nucleotides in length.

3. The siRNA molecule of claim 2 , wherein said antisense region and said sense region are each 19 nucleotides in length.

4. The siRNA molecule of claim 1 , wherein said siRNA molecule has at least one overhang region.

5. The siRNA molecule of claim 1 , wherein said siRNA molecule has no overhang regions.

6. The siRNA molecule of claim 2 , wherein said siRNA molecule has at least one overhang region.

7. The siRNA molecule of claim 2 , wherein said siRNA molecule has no overhang regions.

8. The siRNA molecule of claim 3 , wherein said siRNA molecule has at least one overhang region.

9. The siRNA molecule of claim 3 , wherein said siRNA molecule has no overhang regions.

10. A chemically synthesized double stranded siRNA molecule, wherein:

(a) each strand of said double stranded siRNA molecule is between 19 and 30 nucleotides in length; and

(b) one strand of said siRNA molecule comprises a sequence that is the complement of SEQ ID NO:461.

11. The chemically synthesized double stranded siRNA molecule of claim 10 , wherein each strand of said siRNA molecule is 19-25 nucleotides in length.

12. The chemically synthesized double stranded siRNA molecule of claim 11 , wherein each strand of said siRNA molecule is 19 nucleotides in length.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2016
From: KHVOROVA, ANASTASIA; REYNOLDS, ANGELA; LEAKE, DEVIN; MARSHALL, WILLIAM; READ, STEVEN; SCARINGE, STEPHEN
To: DHARMACON, INC.
Reel/Frame 037936/0636 →
CHANGE OF NAME Recorded Mar 9, 2016
From: DHARMACON, INC.
To: THERMO FISHER SCIENTIFIC BIOSCIENCES INC.
Reel/Frame 038047/0206 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2016
From: THERMO FISHER SCIENTIFIC BIOSCIENCES INC.
To: THERMO FISHER SCIENTIFIC INC.
Reel/Frame 038047/0244 →